Founded as VGBIO, Inc., PhysIQ is dedicated to revolutionizing chronic illness management through predictive analytics and remote patient monitoring. The company's core mission is to provide clinicians with advanced tools to gain new insights into the health status of their chronically ill patients in ambulatory settings. PhysIQ's primary offerings include a personalized physiology data analytics platform that leverages continuous health data to predict and prevent adverse health events, focusing on improving patient outcomes and reducing healthcare costs.
PhysIQ has attracted notable investors and advisors from the healthcare and technology sectors, contributing to its credibility and growth. The company has achieved significant milestones, including successful implementations of its technology in clinical trials and real-world healthcare settings. By enabling proactive health management, PhysIQ has made a substantial impact on the way chronic diseases are monitored and treated, positioning itself as a leader in the digital health landscape.
